Quite an interesting cost benefit analysis here... arising from unconfirmed publication of prices paid for vaccine.
In order to get the vaccine first, by a month, would it be worth UK paying much more outside of European Union procurement?
In order to get the vaccine first, by a month, would it be worth UK paying much more outside of European Union procurement?
https://twitter.com/cbeaune/status/1341691029616029697
French Europe minister there is defending EU response saying Uk is paying 1.5 to 2 times more for vaccines. Only number we have is the NAO one of £2.9bn for 267m courses of 5 diff vaccines, 914m upfront.... 
Could do quite an interesting piece of algebra to backwards engineer how much uk has paid for each vaccine ...
And compare with the list that was tweeted by the Belgian minister...
UK: 100m*£AZ + 60m*£valvena + 40m*£pfizer + 60m*£novavax + 7m*£moderna = £2.9bn
And compare with the list that was tweeted by the Belgian minister...
UK: 100m*£AZ + 60m*£valvena + 40m*£pfizer + 60m*£novavax + 7m*£moderna = £2.9bn
In any event given the total cost of vaccines is £2.9bn... getting access to them a month early, if (Big If) it led to normality being resumed a month earlier... extra cost would be worth it given monthly GDP hit, and £20bn average monthly fiscal hit...
Not yet obviously... but if there is a reasonable chance it could? Is that worth paying say an extra billion for the medicines...?
https://twitter.com/cebikeme/status/1341736562900537344?s=21
interesting discussion this, there’s also the externality for the Europeans of having all their member states get access to vaccine, relatively cheaply. Lesser chances of further waves from less well prepped member states.
Some value to that within EU.
Some value to that within EU.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
